Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bauerschmitz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|January 11, 2003
The risk of rupture of the uterus: an analysis of 1086 births after previous caesarean sectionW Neuhaus, G Bauerschmitz, U Göhring, et al.
Zentralblatt Fur Gynakologie|May 9, 2001
[Risk of uterine rupture after cesarean section--analysis of 1,086 births]W Neuhaus, G Bauerschmitz, U Göhring, et al.
Cancer Gene Therapy|December 25, 2010
Oncolytic adenovirus based on serotype 3O Hemminki, G Bauerschmitz, S Hemmi, et al.
Gene Therapy|March 19, 2010
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumorsS Pesonen, P Nokisalmi, S Escutenaire, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|January 11, 2003
The risk of rupture of the uterus: an analysis of 1086 births after previous caesarean sectionW Neuhaus, G Bauerschmitz, U Göhring, et al.
Zentralblatt Fur Gynakologie|May 9, 2001
[Risk of uterine rupture after cesarean section--analysis of 1,086 births]W Neuhaus, G Bauerschmitz, U Göhring, et al.
Cancer Gene Therapy|December 25, 2010
Oncolytic adenovirus based on serotype 3O Hemminki, G Bauerschmitz, S Hemmi, et al.
Gene Therapy|March 19, 2010
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumorsS Pesonen, P Nokisalmi, S Escutenaire, et al.
Pageof 1